Literature DB >> 2071592

Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2.

E W Howard1, E C Bullen, M J Banda.   

Abstract

To study the activation of human 72-kDa gelatinase, and its relation to tissue inhibitor of metalloproteinases 2 (TIMP-2), we purified human 72-kDa progelatinase both as a complex with TIMP-2 and as a free proteinase. Activation of progelatinase-TIMP-2 complexes with 4-aminophenylmercuric acetate yielded gelatinolytically active enzyme migrating at 62 kDa. TIMP-2 remained bound to the active enzyme. Removal of TIMP-2 from progelatinase by reverse-phase high performance liquid chromatography in the presence of trifluoroacetic acid, followed by complete dialysis in neutral pH buffer, resulted in multiple fragments. These fragments were formed as a result of the cleavage of 72-kDa progelatinase at several locations. Cleavage at the amino terminus was restricted to the removal of the propeptide, except in the case of degradation leading to inactive fragments. Two active species autocatalytically evolved upon removal of TIMP-2 from progelatinase. The 62 kDa-activated gelatinase lacked the amino-terminal propeptide, which is known to be removed upon treatment with 4-aminophenylmercuric acetate. In addition, an active 42.5-kDa fragment lacking both the propeptide and a portion of the carboxyl terminus was formed. This low-molecular-weight active form of 72-kDa progelatinase retained its ability to bind and degrade gelatin. Self-activation and degradation of 72-kDa progelatinase can be prevented by agents that inhibit metalloproteinases, including 1,10-phenanthroline. Evidence presented here suggests that TIMP-2 binds to a stabilization site that is independent of the active site. This stabilization site does not bind TIMP-1 (TIMP). Occupation of this site by TIMP-2 prevents autocatalytic activation and degradation but does not prevent gelatinolysis by the enzyme-inhibitor complex.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2071592

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease.

Authors:  E Louis; C Ribbens; A Godon; D Franchimont; D De Groote; N Hardy; J Boniver; J Belaiche; M Malaise
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

2.  Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis.

Authors:  H Herbst; T Wege; S Milani; G Pellegrini; H D Orzechowski; W O Bechstein; P Neuhaus; A M Gressner; D Schuppan
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

3.  ProMMP-2: TIMP-1 complexes identified in plasma of healthy individuals.

Authors:  Stanley Zucker; Cathleen E Schmidt; Antoine Dufour; Robert C Kaplan; Hyun I Park; Weiping Jiang
Journal:  Connect Tissue Res       Date:  2009       Impact factor: 3.417

4.  Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin.

Authors:  D C von Bredow; A E Cress; E W Howard; G T Bowden; R B Nagle
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

5.  Role of ocular matrix metalloproteinases in peripheral ulcerative keratitis.

Authors:  V A Smith; H B Hoh; D L Easty
Journal:  Br J Ophthalmol       Date:  1999-12       Impact factor: 4.638

6.  IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes.

Authors:  S Lacraz; L P Nicod; R Chicheportiche; H G Welgus; J M Dayer
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

7.  Fragmentation of human polymorphonuclear-leucocyte collagenase.

Authors:  V Knäuper; A Osthues; Y A DeClerck; K E Langley; J Bläser; H Tschesche
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

8.  Identification of tissue inhibitor of metalloproteinase-2 (TIMP-2)-progelatinase complex as the third metalloproteinase inhibitor peak in rheumatoid synovial fluid.

Authors:  T E Cawston; H F Bigg; I M Clark; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

9.  Cell surface-mediated activation of progelatinase A: demonstration of the involvement of the C-terminal domain of progelatinase A in cell surface binding and activation of progelatinase A by primary fibroblasts.

Authors:  R V Ward; S J Atkinson; J J Reynolds; G Murphy
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

10.  Identification, purification and partial characterization of tissue inhibitor of matrix metalloproteinase-2 in bovine pulmonary artery smooth muscle.

Authors:  Malay Mandal; Amritlal Mandal; Sudip Das; Tapati Chakraborti; Sajal Chakraborti
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.